A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients | stella

Learn About Find trials matched to me

About Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients | stella

Back to High-Risk Neuroblastoma trials

Recruiting

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(2 sites)

United States

Children's Hospital Colorado Anschutz Medical, Aurora, Colorado

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Key details

Phase

Large-scale testing

Sponsor

Renaissance Pharma Ltd.

Enrollment target

~144 participants

Started

April 2026

Primary completion

March 2031

Age range

18 Months – 18 Years

Last updated on clinicaltrials.gov in May 2026.

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Enrollment status is pulled from ClinicalTrials.gov and may not reflect real-time availability. If a trial appears full when you reach out, the team will let you know.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.